Axio BioPharma is a biotechnology company specialising in biologics development, using cutting-edge, AI-enhanced techniques to accelerate the journey from lab to patient.

Axio BioPharma provides custom development services for biologics, focusing on accelerating the delivery of life-saving medicines. Their expertise lies in process development, discovery manufacturing, research-grade manufacturing, and, starting in 2028, GMP manufacturing. With a commitment to innovation, Axio uses advanced technologies to optimise biologics manufacturing, setting new industry standards and ensuring rapid, reliable production for clients.

Key Products and Services

• Process Development: Custom strategies for mammalian-expressed proteins, ensuring scalable designs.
• Discovery Manufacturing: Rapid, parallel antibody manufacturing for discovery needs.
• Research-Grade Manufacturing: High-quality proteins for research and development.
• GMP Manufacturing: Services available from 2028, focused on Good Manufacturing Practices.

Axio BioPharma’s mission is to provide the biologics industry with superior manufacturing solutions that expedite drug development, ultimately improving patient outcomes through accelerated delivery of innovative therapies.